Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The OxWell School Survey 2021 highlights that younger children and adolescents are the least willing to have the COVID-19 vaccination. These young people come from the most socioeconomically deprived backgrounds, feel less belonging to their school community and think they have probably had COVID-19 already.

Research conducted at the University of Oxford, with collaborators from UCL and the University of Cambridge found that 36% of 9-year-olds are willing to have a COVID-19 vaccination, compared to 51% of 13-year-olds, and 78% of 17-year-olds. The study included over 27,000 students from 180 schools across Berkshire, Buckinghamshire, Oxfordshire, and Merseyside.

Published in EClinicalMedicine, this is the only large-scale study to ask children and adolescents about their willingness to be vaccinated against COVID-19. The research highlights a need for more resources to help young people feel confident and encouraged to take the COVID-19 vaccine, should it be made available and offered to them.

Associate Professor Mina Fazel, Department of Psychiatry, University of Oxford, said:

 

'Our survey findings show that children become more willing to have the COVID-19 vaccine as they get older. Younger children more often defer to their parents, or primary caregivers, for decisions about healthcare and vaccination, but our data shows how important it is for good quality, accessible information to be provided to better enable our younger populations to understand more about the COVID-19 vaccine and its effects.'

The researchers conclude that it is important to provide information to those communities and individuals who are not naturally connected with their schools, as well as making sure that the vaccination can be offered in a variety of different locations to improve access to those who might find it difficult to get to vaccination sites because of location or timing constraints. There may be some young people who value their privacy and may prefer to be able to have a vaccination without letting others around them know about their choice to get vaccinated.

As vaccination programmes for COVID-19 are rolled out to school populations, more available resources are needed to ensure school students feel the vaccine is safe. In addition, health messaging about vaccine safety and its effects on children:

  • needs to be targeted to both school-aged children, and also to their parents/caregivers,
  • must be delivered and provided in a format, and in locations, where diverse members of the population will be able to see it,
  • and should be effectively shared by trusted sources on social media, as survey findings show that the young people who are most hesitant about having the vaccine use social media more.

Dr Simon R White, Senior Research Associate, University of Cambridge, said:

 

‘Our data shows that there are similarities with adult populations in that those from more deprived socioeconomic backgrounds are more hesitant to have the vaccine. Therefore, targeting parents and caregivers with information and materials, which specifically address the worries they might have for their children is important.’  

Professor Russell Viner, UCL Great Ormond Street Institute of Child Health, said:

 

'Our findings suggest it will be essential to reach out and engage with young people from poorer families and communities with lower levels of trust in vaccination and the health system.  A school-based vaccination program, as planned in England, is an important way of helping reduce these health disparities. However, the teenagers who are least engaged with their school communities may need additional support for us to achieve the highest uptake levels.'

Funding received from the Westminster Foundation to the Department of Psychiatry, University of Oxford, the National Institute for Health Research (NIHR) Applied Research Collaboration Oxford and Thames Valley and the NIHR Biomedical Research Centre, both at the Oxford Health NHS Foundation Trust.

To read the full paper, Willingness of children and adolescents to have a COVID-19 vaccination: results of a large whole schools' survey in England.

Similar stories

Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system

Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.

Arm and shoulder disability and pain after breast cancer surgery reduced by exercise

The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise programme after their operation, a new study has found.

Cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection

The research is highlighted in a special collection of studies that focus on early cancer detection, hailed by the Editors as “cutting edge, and potentially scalable, innovations that have the potential to inform research, policy, and clinical cancer management.”

The legacy of the CLAHRCs 2014-19 – 5 years of NIHR-funded applied health research

This publication compiles key research projects from the NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRCs).

NIHR ARC OxTV supported PRINCIPLE trial 'highly commended' for innovative use of health data

The PRINCIPLE trial, which the NIHR ARC OxTV was a fundamental part of setting up in the early days of the pandemic, has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.